tirzepatide while breastfeeding 🚨 New Research Alert: & — What You Should Know! 🍼 There's a lot of buzz right now about tirzepatide and breastfeeding — and for good reason. 🍼✨ Many postpartum tirzepatide breastfeeding guidance Is Tirzepatide

International Regulatory Landscape Healthcare Provider Considerations Healthcare providers who prescribe or recommend BPC-157 face potential: Disciplinary action from state medical boards Medical license implications (sanctions, restrictions, suspension) Malpractice liability (insurance often excludes experimental treatments) Federal regulatory enforcement Research and Access Legitimate research pathways: Investigational New Drug (IND) application required for human research Institutional Review Board (IRB) approval required GMP standards required for research-grade materials Current access: Research peptide suppliers (variable quality) Some compounding pharmacies (legal status varies) Clinical trials (limited availability) Why This Regulatory Status Exists BPC-157's prohibition stems from: Limited clinical data Only small pilot studies published (~28 human subjects total)

Importantly, long-term data indicate sustained benefits without significant rebound weight gain post- treatment

"Now is the time to book a blood or platelet donation appointment to help prevent any future disruption to patient care." The Red Cross will perform A1C testing on successful blood, platelet and plasma donations made in March

Why We Use Injections Before going further, its important to note that we dont use so-called pain relief injections at our Ladera Ranch podiatrist office